Seventure leads Axial's $25M series B

Axial Biotherapeutics Inc. (Boston, Mass.) raised a $25 million series B led by Seventure Partners on the back of its Parkinson's disease and autism microbiome programs.

Existing investors Longwood Fund, Domain Associates and Heritage Medical Systems, plus undisclosed individual investors, also invested in the round...